From ViaCyte Raises $10M, Moves to Human Trial with New Diabetes Product:

Pancreatic Progenitor Cells (ViaCyte image used with permission).
Pancreatic Progenitor Cells (ViaCyte image used with permission).

Pancreatic Progenitor Cells (ViaCyte image used with permission).